Loomis Sayles & Co. L P cut its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,107,526 shares of the company’s stock after selling 19,119 shares during the quarter. Loomis Sayles & Co. L P’s holdings in HealthEquity were worth $106,267,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity during the 4th quarter worth about $26,000. Smartleaf Asset Management LLC grew its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $39,000. UMB Bank n.a. lifted its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ boosted its position in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after acquiring an additional 445 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at HealthEquity
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is owned by insiders.
HealthEquity Price Performance
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on HQY shares. Wells Fargo & Company boosted their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their target price for the company from $120.00 to $115.00 in a research note on Tuesday. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday, March 14th. Finally, KeyCorp decreased their target price on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $113.31.
View Our Latest Analysis on HQY
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- 3 REITs to Buy and Hold for the Long Term
- Energy Transfer: Powering Data With Dividends and Diversification
- 3 Warren Buffett Stocks to Buy Now
- Qualcomm Stock Is Coiling for a Breakout
- How to Calculate Inflation Rate
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.